- JP-listed companies
- FRONTEO,Inc.
- Financials
- EBITDA margin (%)
FRONTEO,Inc. (2158)
Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
| Period End | EBITDA margin (%) | YoY (%) |
|---|---|---|
| Mar 31, 2025 | 14.3 | +113.04% |
| Mar 31, 2024 | 6.7 | -180.96% |
| Mar 31, 2023 | -8.3 | -135.12% |
| Mar 31, 2022 | 23.6 | +85.33% |
| Mar 31, 2021 | 12.7 | -85261.09% |
| Mar 31, 2020 | -0 | -100.16% |
| Mar 31, 2019 | 9.4 | -3.45% |
| Mar 31, 2018 | 9.8 | -753.58% |
| Mar 31, 2017 | -1.5 | -116.55% |
| Mar 31, 2016 | 9 | -33.66% |
| Mar 31, 2015 | 13.6 |